Atlas Trials

Single Dose ADME Study of [14C]-Rencofilstat in Healthy Male Subjects

Clinical trial NCT05737433 · COMPLETED

Trial details

NCT number
NCT05737433
Sponsor
Hepion Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
NASH With Fibrosis
Start date
2023-03-01
Primary completion
2023-05-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.